Vesilute

FDA APPROVAL PENDING

Preclinical

Longevity

Other

Vesilute

Khavinson Bioregulator | Bladder & Urinary Tract Health

Learn more

Longevity

Vesilute

Other

Amino acid sequence

3

Amino acids

262.22da

Molecular weight

Peptide

Type

Vesilute is a synthetic Khavinson peptide bioregulator composed of the dipeptide Glu-Asp (glutamic acid–aspartic acid), developed at the St. Petersburg Institute of Bioregulation and Gerontology. It targets bladder smooth muscle and urinary tract tissue by modulating gene expression through epigenetic chromatin remodeling. Research use focuses on overactive bladder, nocturia, and age-related urinary dysfunction.

Top researched benefits

Overview of Vesilute

Vesilute binds specific DNA motifs (including the ATTT tetranucleotide) to induce heterochromatin decondensation, reactivating silenced genes in aging bladder and urinary tract cells. Secondary mechanisms include inhibition of glycogen aggregation in smooth muscle cells, reducing calcium-mediated contractility, and improving microcirculation via vascular smooth muscle relaxation.

urinary tract health

  • Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation.
  • May support overall urinary tract function and tissue health.
  • Potential benefits for pelvic tissue health and function.

prostate health men

  • Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue.
  • May help alleviate symptoms associated with benign prostatic hyperplasia.

antiaging protocol

  • Part of comprehensive bioregulator protocols addressing age-related urogenital changes.
  • Supports cellular regeneration in urinary and reproductive tissues.

Typical Dose

1–2 mg per injection

Frequency

once daily

Cycle Duration

10–20 days on, repeated every 3–6 months

Storage

Lyophilized: -20°C or below in sealed packaging with desiccant. Reconstituted: 2–8°C for up to 28 days; avoid freeze-thaw cycles and light exposure.

Chemical Makeup

Key benefits

Reduces overactive bladder symptoms including urinary urgency and daytime frequency — clinical data showed reduction from ~14 to ~11 episodes per day

Increases maximum cystometric bladder capacity, documented in a prospective study from ~267 mL to ~320 mL

Restores bladder wall smooth muscle contractility by normalizing calcium signaling through glycogen aggregation inhibition

Suppresses chronic bladder inflammation and fibrotic scarring, supporting structural tissue integrity over repeated cycles

Community interest

This peptide is still gaining traction in the community.

Khavinson Bioregulator | Bladder & Urinary Tract Health

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Vesilute Molecular Information

View the scientifc details of Vesilute.

3

Amino Acids

Vesilute

Lys

Lys

Position 1

Glu

Glu

Position 2

Asp

Asp

Position 3

Amino acid sequence
LysinePosition 1
Glutamic acidPosition 2
Aspartic acidPosition 3

Molecular Weight

262.22Da

Chain Length

3Amino Acids

Type

Peptide

Vesilute Protocols

Subcutaneous injection is the primary research delivery route for Vesilute, targeting urothelial regeneration and detrusor smooth muscle tone normalization in the bladder. Injections are administered once daily in the morning on an empty stomach, with sites rotated across the abdomen, outer thighs, or upper arms over a 10–20 day course.

GoalDosageFrequencyRoute
Bladder tissue regeneration — standard11 day rangeSubQ
Intensive urothelial repair21 day rangeSubQ
Overactive bladder / chronic cystitis11 day rangeSubQ
Preventive bladder maintenance (adults over 35)11 day rangeSubQ
Nocturia reduction21 day rangeSubQ

Reconstitution Instructions

Materials needed:

Vesilute lyophilized powder vial (20 mg)Bacteriostatic water for injection (2.0 mL per vial)Insulin syringes (1 mL, 29–31 gauge, 5/16–1/2 inch needle)Alcohol swabs (70% isopropyl)Gauze padsSharps disposal container

Steps to reconstitute

  1. Allow the lyophilized Vesilute vial to reach room temperature before reconstitution
  2. Draw 2.0 mL of bacteriostatic water into an insulin syringe
  3. Insert the needle through the rubber stopper of the Vesilute vial at an angle
  4. Inject the BAC water slowly down the inside wall of the vial — never directly onto the powder
  5. Gently swirl the vial to dissolve the powder — do not shake or vortex
  6. Allow the solution to sit for 1–2 minutes until fully clear; discard if cloudy or discolored
  7. Store reconstituted vial in the refrigerator at 2–8°C and use within 28 days
  8. For each injection, clean the chosen site with a 70% alcohol swab and allow to dry for 30 seconds
  9. Pinch a 1–2 inch skin fold and insert the needle at 45–90° depending on subcutaneous tissue depth
  10. Inject slowly over 3–10 seconds, then hold the needle in place for 5–10 seconds before withdrawing
  11. Apply gentle pressure with gauze — do not rub. Rotate sites at least 1–1.5 inches from the previous injection

Vesilute Cycle

The Vesilute Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Tissue-specific effects begin; gene expression modulation
Day 10-20
Cellular function optimization in target tissues
Week 0-0
Effects persist due to bioregulation mechanisms
Week 0-0
Cumulative benefits with regular cycling; tissue health maintenance

Dosing tools

Vesilute Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Vesilute

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Vesilute vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Vesilute
Dosing
1–2 mg per injection
Dosing Frequency
once daily
Cycle Duration
10–20 days on, repeated every 3–6 months
Storage
Lyophilized: -20°C or below in sealed packaging with desiccant. Reconstituted: 2–8°C for up to 28 days; avoid freeze-thaw cycles and light exposure.

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Vesilute interactions with other common peptides and substances.

Longevity

epi

Immunity

Epitalon

COMPATIBLE

Often combined in comprehensive anti-aging bioregulator protocols.

COMPATIBLE

Sexual

pro

Prostamax

SYNERGISTIC

Both target prostate/urogenital health; can be combined for comprehensive support.

SYNERGISTIC

Longevity

thy

Immunity

Thymalin

COMPATIBLE

Different target systems; no known negative interactions.

COMPATIBLE

Healing

vesu

Longevity

Vesugen

COMPATIBLE

Different targets - Vesugen for vascular, Vesilute for bladder/prostate. Can be combined.

COMPATIBLE

Side effects

Contraindications

Known hypersensitivity to peptide components

Active urinary tract infection (treat first)

Pregnancy or breastfeeding

Prostate cancer (consult physician)

Stop signs

Signs of allergic reaction

Unusual urinary symptoms

Unexpected changes in urination patterns

Bad signs

Discolored powderCloudy or particulate solutionDamaged packaging
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

VesiluteResearch References

Vesilute is a preclinical compound

3Research references

Vesilute

Vesilute is a preclinical compound

Khavinson Bioregulator Peptides: Organ-Specific Effects

Vesilute (ED dipeptide) targets bladder and urinary tract tissues with bioregulatory effects.

n.d.

Short Peptides and Urogenital Function

ED dipeptide influences smooth muscle and vascular function in urogenital tissues.

n.d.

Bioregulators in Anti-Aging Medicine

Organ-specific peptide bioregulators including Vesilute support tissue-specific regeneration.

n.d.

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.